Cellectis - ADR XNAS: CLLS

Cellectis - ADR Live Share Price Today, Share Analysis and Chart

about

Cellectis SA is a clinical stage biotechnological company, employing the core proprietary technologies to develop products based on gene-editing, with a portfolio of allogeneic Chimeric Antigen Receptor T-cells, or UCART, product candidates in the fi...

Read More

1.59 0.00 (0.00%)

52.96% Fall from 52W High

34,616 XNAS Volume

XNAS 05 May, 2025 3:31 PM (EDT)

Low Financial Strength
33.3 / 100
Mid Valuation
32.3 / 100
Technically Neutral
49.4 / 100
Await Turnaround These stocks are of poor quality, but mid-range financials and valuations. Their performance may improve based on financials, however our advise would be to be careful before buying these stocks. View Similar Embed DVM

Cellectis - ADR Live Price Chart

Switch to TradingView


Loading Fundamental data..


Loading data..

Cellectis - ADR FAQ

How is Cellectis - ADR today?
Cellectis - ADR today is trading in the red, and is down by 0.00% at 1.59.
Cellectis - ADR is currently trading down 0.00% on an intraday basis. In the past week the stock rose 3.92%. stock has been down -2.45% in the past quarter and fell -46.82% in the past year. You can view this in the overview section.